Form 4: Venu Holding Director Finke Granted 250K Stock Options

Venu Holding Corp. Director Thomas M. Finke was granted 250,000 stock options with an exercise price of $10, following shareholder approval of an amended incentive plan.

Summary

• Thomas M. Finke, a Director of Venu Holding Corp. (VENU), was granted 250,000 stock options.
• The options have an exercise price of $10 per share.
• The grant was approved by the Board of Directors on May 1, 2025, and became effective on October 28, 2025, following shareholder approval of an amendment to the 2023 Omnibus Incentive Compensation Plan.
• The amendment increased the number of shares reserved for issuance under the Plan.
• Of the 250,000 shares underlying the option, 50,000 shares vested immediately on the Grant Effective Date (October 28, 2025).
• An additional 50,000 shares will vest on each annual anniversary of Finke's appointment to the Board, which occurred on May 5, 2025.
• The options expire on May 5, 2033.
• The transaction is exempt from Section 16(b) of the Securities Exchange Act of 1934 under Rule 16b-3(d)(1).

Sentiment

Score: 6

Explanation: The grant of stock options to a director is generally a positive for aligning interests, but also introduces potential future dilution. The shareholder approval of the plan amendment is a positive governance signal.

Positives

• The grant of stock options aligns the interests of Director Thomas M. Finke with those of shareholders, incentivizing long-term performance.
• Shareholder approval of the amendment to the 2023 Omnibus Incentive Compensation Plan demonstrates good corporate governance and transparency regarding equity compensation.

Negatives

• The issuance of 250,000 stock options represents potential future dilution for existing shareholders if exercised.

Future Outlook

The remaining 200,000 shares underlying the option will vest in annual increments of 50,000 shares on each anniversary of the reporting person's appointment to the Board (May 5th).

Management Comments

• The option was approved by the board of directors of Venu Holding Corporation and is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d)(1) promulgated thereunder.
• The option grant was approved by the Issuer's Board on May 1, 2025, subject to shareholder approval of an amendment to the Issuer's Amended and Restated 2023 Omnibus Incentive Compensation Plan.

Industry Context

Granting stock options to directors is a common practice across industries to align their interests with long-term shareholder value creation and to attract and retain qualified board members.

Comparison to Industry Standards

• The use of stock options as a component of director compensation is a widely accepted practice, comparable to incentive structures seen in many publicly traded companies.
• The requirement for shareholder approval of the incentive plan amendment aligns with best practices for corporate governance, ensuring transparency and accountability in equity compensation.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential future dilution upon exercise of options, but also potential for increased director alignment with long-term company performance.
• Director (Thomas M. Finke): Receives a significant equity incentive, aligning personal financial interests with company growth.

Next Steps

• Future vesting of 50,000 shares annually on May 5th until all 250,000 shares are vested.

Key Dates

Keywords

Venu Holding Corp, VENU, Stock Options, Director Compensation, Insider Transaction, SEC Form 4, Equity Incentive Plan, Shareholder Approval